FinBoss.io
CSEN
  • Crypto prices
  • Liquidation War
  • Crypto tools
  • Bitcoin on-chain
  • US macro
  • US stocks
    • Largest US stocks
    • Stock screener
    • Earnings calendar
    • Insider trading
    • Market heatmap
  • Markets
  • Tools
  • Guides
  • FinBot
FinBoss.io
Crypto prices
Liquidation War
Crypto tools
Altcoin Season Index
Big players (on-chain)
Bitcoin halving countdown
Bear market radar
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Largest US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Markets
Stock indices
Commodities
Forex rates
Bear market radar
Famous investors' portfolios
Tools
Dashboards
Investor dashboardTrader dashboardBeginner dashboard
Calculators
Compound interestDCA calculatorDrawdown recovery
Compare
BrokersCrypto exchanges
Přehled sekce Tools →
Guides
FinBot
CSEN
Home
Stocks
Core Scientific Inc
CO

Core Scientific Inc

CORZNASDAQ

Stock · Data from SEC EDGAR 13F · Held by 11 of 87 tracked investors

$14.27
▲ 5.59%
Famous investorshold 11buying 0selling 0
Price (USD)
$14.27
Market cap
$4.6B
P/E ratio
–
Tracked investors holding
11 of 87
Next earnings
5 Nov 2026

Core Scientific Inc at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
27out of 100
  • Valuation8
  • Growth36
  • Profitability36
  • Quality25
  • Debt48
  • Stability8
In its favour
  • ✓The analysts' average target is 121% above the price.
What to watch
  • !The company is loss-making: net profit is negative.

Is the stock expensive?

Expensive

The company has no earnings, so the P/E cannot be calculated.

P/E
–
P/S
10.4×
EV/EBITDA
-89.2×

Is the company growing?

Shrinking
21
22
23
24
25

Revenue over 3 years grew -20.7% a year. Last year 108.8%.

Does it make money?

Loss-making

Revenue and net profit (USD M)

Margins (% of revenue)

Free cash flow and capex (USD M)

Cash and debt (USD M)

Earnings per share (EPS, USD)

Latest quarters (USD M)

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 202628 Jul 20260.18-0.02+1,000%
Mar 20266 May 2026-0.10-0.02-400%
Dec 20252 Mar 2026-0.29-0.27-7.4%
Sep 202524 Oct 2025-0.46-0.85+45.9%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

Chart CORZ

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

11
HM
Howard Marks
Oaktree Capital Management
1.77%$127,788,987▼ -46.9%
JS
Jim Simons
Renaissance Technologies
0.12%$84,942,499▲ +55.7%
CC
Chase Coleman
Tiger Global Management
0.09%$20,907,030New position
PT
Paul Tudor Jones
Tudor Investment Corp
0.08%$55,669,663▲ +1,739.6%
LB
Louis Bacon
Moore Capital Management
0.08%$5,185,046▼ -63.5%
DL
Dan Loeb
Third Point
0.03%$1,381,860New position
IE
Israel Englander
Millennium Management
0.03%$89,775,017▲ +192.8%
GS
George Soros
Soros Fund Management
0.01%$899,412▼ -89.3%
KG
Ken Griffin
Citadel Advisors
0.01%$103,417,712▼ -34.1%
Šn
Švýcarská národní banka
Swiss National Bank
0.01%$12,963,894▲ +3.2%
Ns
Norský státní fond
Norges Bank
0%$22,990,107New position

Frequently asked questions

How much is Core Scientific Inc (CORZ) stock?

Core Scientific Inc shares trade at $14.27, +5.59% over the last trading day. The price is delayed.

What is the market cap of Core Scientific Inc?

The market cap of Core Scientific Inc is about $4.6B.

Which big investors hold Core Scientific Inc?

According to the latest 13F filings, 11 of 87 tracked investors hold Core Scientific Inc, for example Howard Marks, Jim Simons, Chase Coleman.

When will Core Scientific Inc report its next results?

The next earnings report of Core Scientific Inc is expected on 5 Nov 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms of usePrivacy policyCookie policy

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

  • !Net debt is high: at the current free cash flow it would take 5.7 years to repay.
  • !Revenue fell 20.7% a year over 3 years.
  • !The stock is expensive: you pay 87.6 USD for 1 USD of annual earnings.
  • The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

    • Cost of sales 88
    • Research 0.0
    • Operations and selling 82.3
    • Taxes and other 20.1
    • Net profit -90.5

    Out of 100 USD of revenue, -90.5 USD is left as net profit.

    Is it financially healthy?

    Mostly
    Cash
    1.8B USD
    Debt
    4.4B USD
    Free CF
    465M USD

    It could repay its net debt from free cash flow in 5.7 years.

    Does it pay a dividend?

    No dividend

    The company pays no dividend. It reinvests the money or holds it.

    What do analysts expect?

    Strong buy
    Average target
    31.48 USD
    Vs price
    +121%

    21 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    11 of 87

    Among the tracked investors, Howard Marks, Jim Simons, Chase Coleman and others hold the stock according to 13F filings.

    Ratios

    P/E
    –
    Forward P/E
    87.6×
    P/B
    –
    P/S
    10.4×
    PEG
    –
    EV/EBITDA
    -89.2×
    Gross margin
    32.1%
    Operating margin
    6.9%
    Net margin
    0.0%
    ROE
    –
    ROA
    -2.4%
    Debt / equity
    –
    Current ratio
    0.9×
    Revenue growth
    108.8%
    Earnings growth
    –
    Beta
    5.48
    Dividend
    0.00%
    Payout ratio
    0%